Connection
Stefan Sillau to Amyloid beta-Peptides
This is a "connection" page, showing publications Stefan Sillau has written about Amyloid beta-Peptides.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.093 |
|
|
|
-
Pulver RL, Kronberg E, Medenblik LM, Kheyfets VO, Ramos AR, Holtzman DM, Morris JC, Toedebusch CD, Sillau SH, Bettcher BM, Lucey BP, McConnell BV. Mapping sleep's oscillatory events as a biomarker of Alzheimer's disease. Alzheimers Dement. 2024 Jan; 20(1):301-315.
Score: 0.049
-
Johnson NR, Wang AC, Coughlan C, Sillau S, Lucero E, Viltz L, Markham N, Allen C, Dhanasekaran AR, Chial HJ, Potter H. Imipramine and olanzapine block apoE4-catalyzed polymerization of A? and show evidence of improving Alzheimer's disease cognition. Alzheimers Res Ther. 2022 06 29; 14(1):88.
Score: 0.045